Salesforce reported fiscal second-quarter 2027 results on August 26 that, by almost any honest measure, ended the debate about whether Agentforce is a real product cycle. The stock has recovered from a June low of $146.32 but remains down roughly 22% year to date, sitting near $258 this morning. That dislocation is worth examining carefully.
Why This Stock Now
Salesforce reported fiscal 2027 second-quarter revenue of $11.345 billion, up 10.83% year over year and 0.25% above Street estimates for the period ended July 31. Non-GAAP diluted EPS of $5.90 materially exceeded expectations, and GAAP net income of $4.844 billion climbed 73.31% year over year. Management used the momentum to raise full-year guidance. FY27 revenue guidance was raised to $46.1 billion to $46.4 billion, and management said the updated outlook reflects a $300 million constant currency raise versus the prior guide.
The Business
Salesforce is the world’s largest customer relationship management software company, now repositioning its entire platform around Agentforce, its autonomous AI agent product. The question bears repeating: is this a real product cycle or a rebranding exercise?
The Q2 numbers lean hard toward real. Annualized revenue from Agentforce AI products topped $1.5 billion, up over 240% year over year, with the growth rate a quarter earlier already above 200%. Agentforce agentic workflow use hit 3.2 billion actions in the quarter, up 97% sequentially, and bookings from premium Agentforce offerings more than doubled sequentially. A multi-billion dollar U.S. Army expansion is expected to drive up to 55 million monthly Agentforce conversations for the Human Resources Command.
Why Wall Street Is Paying Attention
The bigger move came in bookings. Current remaining performance obligations, the pipeline of contracted but unrecognized revenue, grew 14% year over year to $33.5 billion. Management described it as the strongest quarter for net new annual order value in four years.
The valuation is genuinely cheap relative to history. On a price-to-earnings basis, Salesforce trades at about 20 times earnings, which is below broad software averages. The company also has a $25 billion accelerated share repurchase program in progress. Dreamforce runs September 15 to 17, 2026, and management has said the company expects final settlement of the ASR in October 2026. Dreamforce is the next visible catalyst.
What Could Go Wrong
Skeptics have a legitimate case. Earnings were partially inflated by gains on strategic investments, which can swing quarter to quarter, while the core Agentforce Apps segment continues to lag company averages, growing at just 8% constant currency. The Agentforce Apps segment, which contains the core Sales, Service, and Commerce clouds, grew at just 8% constant currency, significantly below the total company average of 11%, showing stagnation in the core SaaS product. The revenue guidance raise also includes expected contributions from pending acquisitions, rather than being purely organic.
The broader risk is competitive. Microsoft Copilot, ServiceNow’s AI agents, and a wave of vertical-specific AI tools are all competing for the same enterprise budget. Any customer that decides to build in-house reduces the total addressable market faster than Agentforce can fill it.
The Bottom Line
Salesforce has had a brutal 2026 relative to the market, falling from $369 at the December 2024 peak to a June low of $146.32. The recovery since then is real but incomplete. At $258, the stock still prices in meaningful AI skepticism despite an Agentforce trajectory that is now accelerating rather than stalling. Dreamforce in mid-September is where management will need to show that the guidance raise reflects durable organic demand. If they can, the gap between 20 times earnings and broader software multiples narrows quickly.
